Fan Xin-Xin, Du Er-Deng, Li Jia-Qi, Zhao Li-Li, Wang Yu-Lin, Peng Ming-Guo
School of Environmental & Safety Engineering, Changzhou University, Changzhou 213164, China.
Huan Jing Ke Xue. 2018 Apr 8;39(4):1645-1653. doi: 10.13227/j.hjkx.201707042.
The by-products produced during chlorination of pharmaceutically active compounds (PhACs) have created widespread public concern. Chlorination of a typical PhAC, naproxen (NAP), was studied. NAP chlorination parameters, intermediates identification, chlorination mechanism, and risk assessment during chlorination process have also been discussed. The results showed that NAP chlorination could fit well with the fist-order kinetics. The rate of removal and rate constants of NAP chlorination decreased with increasing initial NAP concentration and ammonium dosage, while these values increased with increasing initial free chlorine concentration. Acidic condition of the solution could significantly promote NAP chlorination. Five intermediates were identified by HPLC-MS/MS, and the mechanism of NAP chlorination was also put forward. Vibrio fischeri toxicity analysis and ESCOAR prediction indicated that higher toxicity intermediates were produced during NAP chlorination, which pose a potential threat to drinking water safety.
药物活性化合物(PhACs)氯化过程中产生的副产物引起了公众的广泛关注。对典型的药物活性化合物萘普生(NAP)的氯化过程进行了研究。还讨论了NAP氯化参数、中间体鉴定、氯化机理以及氯化过程中的风险评估。结果表明,NAP氯化过程符合一级动力学。NAP氯化的去除率和速率常数随初始NAP浓度和铵用量的增加而降低,而随初始游离氯浓度的增加而升高。溶液的酸性条件可显著促进NAP氯化。通过HPLC-MS/MS鉴定出5种中间体,并提出了NAP氯化的机理。费氏弧菌毒性分析和ESCOAR预测表明,NAP氯化过程中产生了毒性更高的中间体,这对饮用水安全构成了潜在威胁。